RhumbLine Advisers’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.7M Sell
1,095,995
-34,159
-3% -$2.67M 0.07% 222
2025
Q1
$81.9M Buy
1,130,154
+44,249
+4% +$3.21M 0.08% 227
2024
Q4
$80.4M Sell
1,085,905
-37,002
-3% -$2.74M 0.07% 220
2024
Q3
$74.1M Sell
1,122,907
-73,240
-6% -$4.83M 0.07% 247
2024
Q2
$110M Sell
1,196,147
-42,373
-3% -$3.91M 0.1% 161
2024
Q1
$118M Buy
1,238,520
+7,323
+0.6% +$700K 0.11% 160
2023
Q4
$93.9M Sell
1,231,197
-7,402
-0.6% -$564K 0.1% 177
2023
Q3
$85.8M Sell
1,238,599
-17,588
-1% -$1.22M 0.1% 173
2023
Q2
$118M Buy
1,256,187
+9,826
+0.8% +$927K 0.13% 131
2023
Q1
$103M Buy
1,246,361
+65,937
+6% +$5.45M 0.13% 144
2022
Q4
$88.1M Buy
1,180,424
+32,133
+3% +$2.4M 0.12% 165
2022
Q3
$94.9M Buy
1,148,291
+19,525
+2% +$1.61M 0.14% 132
2022
Q2
$107M Buy
1,128,766
+21,812
+2% +$2.07M 0.16% 119
2022
Q1
$130M Buy
1,106,954
+30,106
+3% +$3.54M 0.17% 105
2021
Q4
$140M Sell
1,076,848
-1,950
-0.2% -$253K 0.17% 102
2021
Q3
$122M Sell
1,078,798
-11,416
-1% -$1.29M 0.17% 109
2021
Q2
$113M Sell
1,090,214
-58,922
-5% -$6.1M 0.15% 120
2021
Q1
$96.1M Sell
1,149,136
-51,321
-4% -$4.29M 0.13% 136
2020
Q4
$110M Sell
1,200,457
-8,628
-0.7% -$787K 0.15% 128
2020
Q3
$96.5M Buy
1,209,085
+5,841
+0.5% +$466K 0.15% 126
2020
Q2
$83.2M Sell
1,203,244
-45,551
-4% -$3.15M 0.14% 136
2020
Q1
$78.5M Buy
1,248,795
+31,335
+3% +$1.97M 0.16% 123
2019
Q4
$94.7M Buy
1,217,460
+67,851
+6% +$5.28M 0.16% 124
2019
Q3
$84.3M Buy
1,149,609
+9,825
+0.9% +$720K 0.15% 133
2019
Q2
$70.2M Buy
1,139,784
+17,037
+2% +$1.05M 0.13% 151
2019
Q1
$71.6M Sell
1,122,747
-25,218
-2% -$1.61M 0.14% 140
2018
Q4
$58.6M Sell
1,147,965
-47,226
-4% -$2.41M 0.13% 152
2018
Q3
$69.4M Sell
1,195,191
-31,191
-3% -$1.81M 0.13% 148
2018
Q2
$59.5M Buy
1,226,382
+44,190
+4% +$2.14M 0.12% 171
2018
Q1
$55M Sell
1,182,192
-31,008
-3% -$1.44M 0.11% 184
2017
Q4
$45.6M Buy
1,213,200
+32,943
+3% +$1.24M 0.09% 218
2017
Q3
$43M Sell
1,180,257
-16,032
-1% -$584K 0.09% 224
2017
Q2
$47.2M Sell
1,196,289
-8,352
-0.7% -$329K 0.11% 198
2017
Q1
$37.8M Buy
1,204,641
+14,418
+1% +$452K 0.09% 239
2016
Q4
$37.2M Buy
1,190,223
+60,111
+5% +$1.88M 0.09% 221
2016
Q3
$45.4M Buy
1,130,112
+22,587
+2% +$908K 0.13% 168
2016
Q2
$36.8M Buy
1,107,525
+38,622
+4% +$1.28M 0.11% 194
2016
Q1
$31.4M Buy
1,068,903
+48,468
+5% +$1.43M 0.1% 208
2015
Q4
$26.9M Buy
1,020,435
+10,743
+1% +$283K 0.09% 227
2015
Q3
$23.9M Buy
1,009,692
+3,300
+0.3% +$78.2K 0.08% 249
2015
Q2
$23.9M Buy
1,006,392
+82,266
+9% +$1.95M 0.08% 257
2015
Q1
$21.9M Buy
924,126
+18
+0% +$427 0.06% 271
2014
Q4
$19.6M Sell
924,108
-28,098
-3% -$597K 0.06% 300
2014
Q3
$16.2M Sell
952,206
-1,620
-0.2% -$27.6K 0.05% 336
2014
Q2
$13.6M Sell
953,826
-71,310
-7% -$1.02M 0.04% 397
2014
Q1
$12.7M Sell
1,025,136
-37,884
-4% -$468K 0.04% 416
2013
Q4
$11.7M Sell
1,063,020
-97,278
-8% -$1.07M 0.03% 442
2013
Q3
$13.5M Sell
1,160,298
-4,098
-0.4% -$47.6K 0.04% 398
2013
Q2
$13M Buy
+1,164,396
New +$13M 0.04% 385